Absci Management

Management criteria checks 0/4

Absci's CEO ist Sean McClain , ernannt in Aug 2011, hat eine Amtszeit von 12.33 Jahren. Die jährliche Gesamtvergütung beträgt $4.01M , bestehend aus 14.9% Gehalt und 85.1% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 9.3% der Aktien des Unternehmens, im Wert von $19.96M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 1.3 Jahre bzw. 1.5 Jahre.

Key information

Sean McClain

Chief executive officer

US$4.0m

Total compensation

CEO salary percentage14.9%
CEO tenure12.7yrs
CEO ownership7.7%
Management average tenure1.4yrs
Board average tenure1.2yrs

Recent management updates

Recent updates

Absci: Differentiated Antibody Discovery Play

Feb 27

Absci GAAP EPS of -$0.32 misses by $0.01, revenue of $1M misses by $0.68M

Aug 11

Absci teams up to help develop antibody drugs for cancer

Jul 07

Merck And Absci: AI-Driven Drug Development Deal Has Promise, But May Take Years To Pay Out

Jan 10

IPO Day With Absci CEO Sean McClain - The Google Of Synthetic Biology (Video)

Jul 22

CEO Compensation Analysis

How has Sean McClain's remuneration changed compared to Absci's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-US$111m

Sep 30 2023n/an/a

-US$106m

Jun 30 2023n/an/a

-US$112m

Mar 31 2023n/an/a

-US$99m

Dec 31 2022US$4mUS$600k

-US$105m

Sep 30 2022n/an/a

-US$111m

Jun 30 2022n/an/a

-US$107m

Mar 31 2022n/an/a

-US$121m

Dec 31 2021US$4mUS$505k

-US$103m

Sep 30 2021n/an/a

-US$84m

Jun 30 2021n/an/a

-US$73m

Mar 31 2021n/an/a

-US$48m

Dec 31 2020US$1mUS$260k

-US$49m

Vergütung im Vergleich zum Markt: SeanDie Gesamtvergütung ($USD4.01M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD2.14M).

Entschädigung vs. Einkommen: SeanDie Bezüge der Mitarbeiter sind gestiegen, während das Unternehmen unrentabel ist.


CEO

Sean McClain (32 yo)

12.7yrs

Tenure

US$4,013,426

Compensation

Mr. Sean Mcclain is the Founder of Absci Corporation (formerly known as AbSci, LLC) and serves as its Chief Executive Officer since August 2011 and Director since its formation in October 2020. Mr. Mcclain...


Leadership Team

NamePositionTenureCompensationOwnership
Sean McClain
Founder12.7yrsUS$4.01m7.66%
$ 45.9m
Zachariah Jonasson
Chief Business Officer & CFOless than a yearUS$155.12k0.0080%
$ 47.8k
Andreas Busch
Chief Innovation Officer & Member of Scientific Advisory Board1.5yrsUS$9.47mno data
Todd Bedrick
Senior VP & Chief Accounting Officer1.8yrsno data0.0027%
$ 15.9k
Alexander Khan
VP of Finance & Head of Investor Relations1.1yrsno datano data
Karin Wierinck
Chief People Officer1.3yrsno datano data
Melissa Patterson
Chief of Staff2.1yrsno datano data
Jens Plassmeier
Senior VP of Biologics Discovery Technology2.3yrsno datano data
Wen Sha
Chief of Staff2.3yrsno datano data
Christine Lemke
Senior Vice President of Portfolio & Growth Strategy1.2yrsno datano data
Christian Stegmann
Senior Vice President of Drug Creation1.2yrsno datano data
Amaro Taylor-Weiner
Chief AI Officerless than a yearno datano data

1.4yrs

Average Tenure

49yo

Average Age

Erfahrenes Management: ABSIDas Führungsteam des Unternehmens gilt nicht als erfahren ( 1.3 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.


Board Members

NamePositionTenureCompensationOwnership
Sean McClain
Founder3.5yrsUS$4.01m7.66%
$ 45.9m
Andreas Busch
Chief Innovation Officer & Member of Scientific Advisory Boardless than a yearUS$9.47mno data
Karen McGinnis
Lead Independent Director3.7yrsUS$172.49k0.013%
$ 79.7k
François van Houten
Directorless than a yearno datano data
Daniel Rabinovitsj
Independent Director1.4yrsUS$119.00k0%
$ 0
Timothy Lu
Member of Scientific Advisory Board1.2yrsno datano data
Menelas Nicolas Pangalos
Director & Member of Scientific Advisory Boardless than a yearno datano data
Joseph Sirosh
Independent Director2.3yrsUS$297.86k0%
$ 0
Amrit Nagpal
Independent Director3.5yrsUS$106.82kno data
Victor Greiff
Member of Scientific Advisory Board1.2yrsno datano data
Hubert Truebel
Member of Scientific Advisory Board1.2yrsno datano data

1.2yrs

Average Tenure

56yo

Average Age

Erfahrener Vorstand: ABSIDie Vorstandsmitglieder gelten nicht als erfahren ( 1.5 Jahre durchschnittliche Amtszeit), was auf einen neuen Vorstand hindeutet.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.